Table 3.
Participants
|
Total (%)
|
Physician led
|
CHW led
|
χ2 value
|
Significance
|
Discussed prostate cancer screening with their doctors | 73.9 | 59 | 26 | 2.527 | .112 |
Discussed benefits of screening with their doctors | 64.3 | 52 | 22 | 2.336 | .126 |
Discussed the risks of screening | 42.1 | 34 | 14 | 1.276 | .259 |
Doctors informed that experts disagree about whether men should have a PSA test | 23.5 | 22 | 5 | 4.114 | .043 |
PSA, prostate-specific antigen